13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001697013
申报总市值
US$19.3亿
US$19.3亿
67 檔
29.5%
根据最新整理的 13F 季度数据集，Eversept Partners, LP 于 Q3 2024 结束时的管理资产规模为 US$19.3亿。该机构在本季度申报了 67 档美股持仓，呈现出该时期的主要投资地图。
在 Q3 2024，Eversept Partners, LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 32 个仓位并完全清仓 17 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Eversept Partners, LP 的前 5 大核心持股（包含 GSK, QQQ, NTRA 等）合计占整体申报市值的 29.5%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | GSK | Gsk Plc-spon Adr | 股票-医疗保健 | 11.36% | -3.89% | +16.99% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-科技型 | 8.34% | -3.49% | -12.61% | |
| 3 | NTRA | Natera Inc | 股票-医疗保健 | 7.57% | -1.58% | -25.85% | |
| 4 | VERA | Vera Therapeutics Inc | 股票-其他 | 6.21% | +0.32% | +0.34% | |
| 5 | INSM | Insmed Inc | 股票-医疗保健 | 5.45% | +0.55% | -5.73% | |
| 6 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 5.41% | -0.38% | +13.61% | |
| 7 | RVTY | Revvity Inc | 股票-医疗保健 | 4.11% | +0.09% | +4.01% | |
| 8 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 3.99% | — | -48.17% | |
| 9 | TEVA | Teva Pharmaceutical-sp Adr | 股票-医疗保健 | 3.99% | — | -31.48% | |
| 10 | CYH | Community Health Systems Inc | 股票-其他 | 3.65% | +0.01% | +9.19% | |
| 11 | TECH | Bio-techne CORP | 股票-医疗保健 | 3.63% | -0.28% | +22.20% | |
| 12 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 3.59% | +0.01% | -4.72% | |
| 13 | UTHR | United Therapeutics CORP | 股票-医疗保健 | 3.21% | -0.17% | -44.36% | |
| 14 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-大型股与成长 | 2.36% | -3.67% | EXIT | |
| 15 | ZIMV | Zimvie Inc | 股票-其他 | 2.25% | — | +169.75% | |
| 16 | HQY | Healthequity Inc | 股票-医疗保健 | 1.79% | -0.23% | EXIT | |
| 17 | RGEN | Repligen CORP | 股票-医疗保健 | 1.67% | -0.65% | -15.80% | |
| 18 | VTRS | Viatris Inc | 股票-医疗保健 | 1.37% | — | +29.87% | |
| 19 | PTGX | Protagonist Therapeutics Inc | 股票-其他 | 1.37% | +0.37% | NEW | |
| 20 | CLDX | Celldex Therapeutics Inc | 股票-其他 | 1.32% | +0.46% | -10.76% | |
| 21 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 1.29% | +0.23% | +3.17% | |
| 22 | VRDN | Viridian Therapeutics Inc | 股票-其他 | 1.08% | +0.05% | +21.81% | |
| 23 | MNKD | Mannkind CORP | 股票-其他 | 0.86% | — | -11.72% | |
| 24 | BHC | Bausch Health Cos Inc | 股票-医疗保健 | 0.86% | — | — | |
| 25 | TVTX | Travere Therapeutics Inc | 股票-其他 | 0.83% | +1.50% | -20.28% | |
| 26 | HUM | Humana Inc | 股票-医疗保健 | 0.73% | +0.64% | NEW | |
| 27 | DHR | Danaher CORP | 股票-医疗保健 | 0.73% | — | -5.94% | |
| 28 | CNC | Centene CORP | 股票-医疗保健 | 0.70% | -0.19% | EXIT | |
| 29 | ELV | Elevance Health Inc | 股票-医疗保健 | 0.69% | — | +32.80% | |
| 30 | FTRE | Fortrea Holdings Inc | 股票-医疗保健 | 0.63% | — | — | |
| 31 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 0.62% | — | — | |
| 32 | EOLS | Evolus Inc | 股票-其他 | 0.50% | — | -21.13% | |
| 33 | BHVN | Biohaven Ltd. | 股票-其他 | 0.45% | +0.40% | NEW | |
| 34 | ARQT | Arcutis Biotherapeutics Inc | 股票-其他 | 0.44% | -0.54% | -17.26% | |
| 35 | STRO | Sutro Biopharma, Inc. | 股票-其他 | 0.44% | — | +5.91% | |
| 36 | BKD | Brookdale Senior Living Inc | 股票-其他 | 0.40% | +0.27% | -44.32% | |
| 37 | NAMS | NewAmsterdam Pharma Company N.V. | 股票-其他 | 0.35% | — | -6.83% | |
| 38 | FNAUSD | Paragon 28 Inc | 股票-其他 | 0.34% | — | — | |
| 39 | GOSS | Gossamer Bio Inc | 股票-其他 | 0.34% | — | -9.22% | |
| 40 | TSVT* | 2seventy Bio Inc | 股票-其他 | 0.32% | — | -9.90% | |
| 41 | KPTIEUR | Karyopharm Therapeutics Inc | 股票-其他 | 0.32% | — | +11.24% | |
| 42 | AVTR | Avantor Inc | 股票-医疗保健 | 0.30% | -1.23% | EXIT | |
| 43 | BCRX | Biocryst Pharmaceuticals Inc | 股票-其他 | 0.28% | -0.56% | -53.55% | |
| 44 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 0.27% | -0.40% | EXIT | |
| 45 | KURA | Kura Oncology Inc | 股票-其他 | 0.26% | — | +166.05% | |
| 46 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 0.25% | +0.73% | -42.07% | |
| 47 | ✓ | Merus N V | 股票-其他 | 0.23% | — | +2.68% | |
| 48 | STAA | Staar Surgical Co | 股票-其他 | 0.23% | — | — | |
| 49 | PBYI | Puma Biotechnology Inc | 股票-其他 | 0.23% | — | -2.65% | |
| 50 | ZLAB | Zai Lab Ltd-adr | 股票-其他 | 0.22% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | GSK | Gsk Plc-spon Adr | +2.2% | +16.99% | 加仓 |
| 2 | CYH | Community Health Systems Inc | +1.8% | +9.19% | 加仓 |
| 3 | ZIMV | Zimvie Inc | +1.3% | +169.75% | 加仓 |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | +1.2% | +94.81% | 加仓 |
| 5 | VERA | Vera Therapeutics Inc | +1.2% | +0.34% | 加仓 |
| 6 | TECH | Bio-techne CORP | +1% | +22.20% | 加仓 |
| 7 | RVTY | Revvity Inc | +0.9% | +4.01% | 加仓 |
| 8 | BHC | Bausch Health Cos Inc | +0.9% | NEW | 新建仓 |
| 9 | FTRE | Fortrea Holdings Inc | +0.6% | NEW | 新建仓 |
| 10 | ITCIEUR | Intra-cellular Therapies Inc | +0.6% | NEW | 新建仓 |
| 11 | HCA | Hca Healthcare Inc | +0.6% | -4.72% | 减仓 |
| 12 | VRDN | Viridian Therapeutics Inc | +0.6% | +21.81% | 加仓 |
| 13 | BHVN | Biohaven Ltd. | +0.5% | NEW | 新建仓 |
| 14 | VTRS | Viatris Inc | +0.4% | +29.87% | 加仓 |
| 15 | FNAUSD | Paragon 28 Inc | +0.3% | NEW | 新建仓 |
| 16 | SNDX | Syndax Pharmaceuticals Inc | +0.3% | +13.61% | 加仓 |
| 17 | STAA | Staar Surgical Co | +0.2% | NEW | 新建仓 |
| 18 | ZLAB | Zai Lab Ltd-adr | +0.2% | NEW | 新建仓 |
| 19 | ZBIO | Zenas Biopharma Inc | +0.2% | NEW | 新建仓 |
| 20 | TVTX | Travere Therapeutics Inc | +0.2% | -20.28% | 减仓 |
| 21 | MRVI | Maravai Lifesciences Hldgs-a | +0.2% | NEW | 新建仓 |
| 22 | PTGX | Protagonist Therapeutics Inc | +0.2% | -11.99% | 减仓 |
| 23 | CNC | Centene CORP | +0.2% | +16.52% | 加仓 |
| 24 | KURA | Kura Oncology Inc | +0.2% | +166.05% | 加仓 |
| 25 | ELV | Elevance Health Inc | +0.2% | +32.80% | 加仓 |
| 26 | INSM | Insmed Inc | +0.2% | -5.73% | 减仓 |
| 27 | AVTR | Avantor Inc | +0.1% | +34.27% | 加仓 |
| 28 | MREO | Mereo Biopharma Group Pl-adr | +0.1% | +56.78% | 加仓 |
| 29 | STRO | Sutro Biopharma, Inc. | +0.1% | +5.91% | 加仓 |
| 30 | EOLS | Evolus Inc | +0.1% | -21.13% | 减仓 |
| 31 | ✓ | +0.1% | NEW | 新建仓 | |
| 32 | MNKD | Mannkind CORP | +0.1% | -11.72% | 减仓 |
| 33 | IQV | Iqvia Holdings Inc | 0% | +7.88% | 加仓 |
| 34 | DHR | Danaher CORP | 0% | -5.94% | 减仓 |
| 35 | TSVT* | 2seventy Bio Inc | 0% | -9.90% | 减仓 |
| 36 | XOMA | Xoma Royalty Corporation | 0% | +2.59% | 加仓 |
| 37 | KPTIEUR | Karyopharm Therapeutics Inc | 0% | +11.24% | 加仓 |
| 38 | ABSI | Absci CORP | — | -16.17% | 减仓 |
| 39 | ICLR | ICON Public Limited Company | — | +8.12% | 加仓 |
| 40 | GOSS | Gossamer Bio Inc | — | -9.22% | 减仓 |
| 41 | ACIU | AC Immune SA | — | — | 不变 |
| 42 | RGEN | Repligen CORP | 0% | -15.80% | 减仓 |
| 43 | ✓ | Affimed N V | 0% | — | 不变 |
| 44 | MCRB1EUR | Seres Therapeutics Inc | 0% | EXIT | 清仓 |
| 45 | IFRX | InflaRx N.V. | 0% | +3.50% | 加仓 |
| 46 | STOK | Stoke Therapeutics Inc | 0% | -15.13% | 减仓 |
| 47 | TRML | Tourmaline Bio Inc | 0% | -58.80% | 减仓 |
| 48 | GTHXEUR | G1 Therapeutics Inc | 0% | EXIT | 清仓 |
| 49 | ✓ | Merus N V | 0% | +2.68% | 加仓 |
| 50 | AUTL | Autolus Therapeutics PLC | -0.1% | -33.45% | 减仓 |
根据 SEC 官方 Form 13F 申报备案，Eversept Partners, LP 在 Q3 2024 季度的美股持仓总市值约为 US$19.3亿，共申报了 67 个公开持股仓位。
在 Q3 2024 季度，Eversept Partners, LP 按市值排列的前三大核心持股分别为：GSK (11.4%)、QQQ (8.3%)、NTRA (7.6%)。其中最大持股仓位 GSK 占据整体投资组合约 11.4% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
BHC
市值: US$1249.2万
本季最大获利了结 / 清仓标的
NVO
前期市值: US$2097.6万
在 Q3 2024 季度中，Eversept Partners, LP 共进行了 82 项持仓异动，包含新建仓 10 个仓位、加仓 23 个仓位、减仓 32 个仓位以及清仓 17 个仓位。 其中最大新建仓标的为 BHC。 本季清仓仓位包含 NVO。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。